Science Explorer Back to mapMap
Discussion
Researcher · Amgen (United States) · United States

Wenjun Ouyang

Wenjun Ouyang publishes mostly in Immunology, Oncology and Molecular Biology, on topics such as Psoriasis: Treatment and Pathogenesis, Immune Cell Function and Interaction and IL-33, ST2, and ILC Pathways.

ORCID 0000-0002-1811-5864 OpenAlex
World rank
#26,646
of 7,710,434 ranked researchers
Rank in United States
#9,981
of 1,627,098
Works
159
Citations
37k
Citations per work
235.2
h-index
78
i10-index 124Top 1% in Immunology
Wenjun Ouyang

What does Wenjun Ouyang research?

Wenjun Ouyang's work is mostly in Immunology and Microbiology (42%), Medicine (20%), Biochemistry, Genetics and Molecular Biology (8%).

Life Sciences: 80 works · 50.4% of their workImmunology and Microbiology: 67 works · 41.9% of their workImmunology: 67 works · 41.9% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 8.5% of their workMolecular Biology: 14 works · 8.5% of their workEverything else: 47 works · 29.4% of their workHealth Sciences: 32 works · 20.2% of their workMedicine: 32 works · 20.2% of their workOncology: 14 works · 9.1% of their workDermatology: 7 works · 4.7% of their workEpidemiology: 5 works · 3.2% of their workPathology and Forensic Medicine: 5 works · 3.2% of their workTHEIR WORKWenjun Ouyang159works
Life Sciences50%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Immunology and Microbiology6741.9%
    2. Biochemistry, Genetics and Molecular Biology148.5%
  2. Everything else4729.4%
    1. Medicine3220.2%
  1. 1Immunology42% of their works
  2. 2Oncology9% of their works
  3. 3Molecular Biology8% of their works
  4. 4Dermatology5% of their works
  5. 5Epidemiology3% of their works
  6. 6Pathology and Forensic Medicine3% of their works

Research topics

Which keywords describe Wenjun Ouyang's research?

The keywords of their largest research topics: Regulatory T Cells, TGF-ß, IL-17, TH17 Cells, Inflammation, Natural Killer Cells, NK Cell Recognition and Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Regulatory T Cells892 topics
  2. TGF-ß792 topics
  3. IL-17531 topic
  4. TH17 Cells531 topic
  5. Inflammation483 topics
  6. NK Cell Recognition371 topic
  7. Natural Killer Cells371 topic
  8. Cancer362 topics
  9. IL-33361 topic
  10. Innate Lymphoid Cells361 topic
  11. CD4+CD25+261 topic
  12. Foxp3261 topic
  13. IL-6261 topic
  14. STAT3261 topic
  15. Filaggrin191 topic
  16. Skin Microbiome191 topic
  17. Pattern Recognition Receptors121 topic
  18. Toll-like Receptors121 topic
  19. NF-?B101 topic
  20. Signaling101 topic

Where does Wenjun Ouyang work?

Wenjun Ouyang's main affiliation in the publication record is Amgen (United States), United States.

How many publications and citations does Wenjun Ouyang have?

OpenAlex counts 159 works and 37,399 citations for Wenjun Ouyang, an h-index of 78, ranking #26,646 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Wenjun Ouyang

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Wenjun Ouyang. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.